2021
McGrath LJ, Nielson C, Saul B, Breskin A, Yu Y, Nicolaisen SK, … Kelsh M , et al. 2021. Lessons learned using real-world data to emulate randomized trials: A case study of treatment effectiveness for newly diagnosed immune thrombocytopenia. Clin Pharmacol Ther 110(6):1570–1578; doi: 10.1002/cpt.2399 . PMID: 34416023.
View Abstract
Topics: Epidemiology
Hathway J, Miller-Wilson L, Sharma A, Jensen I , Yao W, Raza S, et al. 2021. The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population. J Mark Access Health Policy, 9(1):1948670; doi: 10.1080/20016689.2021.1948670 .
View Abstract
Topics: Cancer
Sacks NC , Healey BE, Cyr PL , Slocomb T, James E, Beggs AH, Graham RJ. 2021. Costs and health resource use in patients with X-linked myotubular myopathy: insights from U.S. commercial claims. J Manag Care Spec Pharm 27(8):1019–1026; doi: 10.18553/jmcp.2021.20501 . PMID: 33843254.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Mayne TJ, Nordyke RJ , Schold JD, Weir MR, Mohan S. 2021. Defining a minimal clinically meaningful difference in 12-month estimated glomerular filtration rate for clinical trials in deceased donor kidney transplantation. Clin Transplant 35(7):e14326; doi: 10.1111/ctr.14326 . PMID: 33896052.
View Abstract
Topics: Epidemiology
Haddadin Z, Rankin DA, Lipworth L, Suh M , McHenry R, Blozinski A, Salib George S, Fernandez KN, et al. 2021. Respiratory virus surveillance in infants across different clinical settings. J Pediat 234(July):p164-p171; doi: 10.1016/j.jpeds.2021.03.036 . PMID: 33774057.
View Abstract
Topics: Epidemiology
Dean R, Jensen IS, Cyr PL , Miller B, Maru B, Sproule DM, Feltner DE, et al. 2021. An updated cost-utility model for onasemnogene abeparvovec (Zolgensma®) in spinal muscular atrophy type 1 patients and comparison with evaluation by the Institute for Clinical and Effectiveness Review (ICER). J Mark Access Health Pol 9(1):1889841; doi: 10.1080/20016689.2021.1889841 .
Topics: Health Economics and Outcomes Research (HEOR)
Alexander DD, Pastula ST , Riordan AS. 2021. Epidemiology of lung cancer among acrylonitrile-exposed study populations: A meta-analysis. Regul Toxicol Pharmacol 122(June):104896; doi: 10.1016/j.yrtph.2021.104896 . PMID: 33617939.
View Abstract
Topics: Cancer , Epidemiology , Systematic Review
Proctor DM, Bhat V, Suh M , Reichert H , Jiang X , Thompson CM. 2021. Inhalation cancer risk assessment for environmental exposure to hexavalent chromium: Comparison of margin-of-exposure and linear extrapolation approaches. Regul Toxicol Pharmacol 124(August):104969; doi: 10.1016/j.yrtph.2021.104969 . PMID: 34089813.
View Abstract
Topics: Cancer , chromium , Exposure Assessment , risk assessment
Rehorn M, Sacks NC , Emden MR, Healey B, Preib MT, Cyr PL , Pokorney SD. 2021. Prevalence and incidence of patients with paroxysmal supraventricular tachycardia in the United States. J Cardiovasc Electrophysiol 32(8):2199-2206; doi: 10.1111/jce.15109 .
View Abstract
Topics: Epidemiology
Cuellar AE, Adams LM, de Jonge E, Espina V, Espinoza L, Frankenfeld CL , Hines D, Kornienko O, et al. 2021. Protocol for the Mason: Health Starts Here prospective cohort study of young adult college students. BMC Public Health 21(1):897; doi: 10.1186/s12889-021-10969-5 . PMID: 33980206.
View Abstract
A Division of